SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-23-094413
Filing Date
2023-12-08
Accepted
2023-12-08 16:36:22
Documents
5
Effectiveness Date
2023-12-08

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea189700-s8_unicycive.htm S-8 78674
2 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP ea189700ex5-1_unicycive.htm EX-5.1 11122
3 CONSENT OF MAYER HOFFMAN MCCANN P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING F ea189700ex23-1_unicycive.htm EX-23.1 2199
4 FILING FEE TABLE ea189700ex-fee_unicycive.htm EX-FILING FEES 25219
5 GRAPHIC ex5-1_001.jpg GRAPHIC 8048
  Complete submission text file 0001213900-23-094413.txt   129434
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275965 | Film No.: 231475936
SIC: 2834 Pharmaceutical Preparations